Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Europe
Europe.png
Filter     Order     Display # 
Date Item Title Hits
07 Jul 2006 PLIVA Announces FDA Approvals for Azithromycin Oral Suspension, Warfarin and Ondansetron Hydrochloride 3157
06 Jul 2006 Lipsovir Has Entered Phase III Clinical Study 1546
14 Jun 2006 Committee For Medicinal Products For Human Use May 2006 Plenary Meeting Monthly Report 1328
12 Jun 2006 Novozymes acquires Delta Biotechnology Ltd 1288
08 Jun 2006 Humax-CD38 Shows Unique Property In Preclinical Studies 1310
08 Jun 2006 MorphoSys and OncoMed Pharmaceuticals Sign Agreement for Use of HuCAL GOLD in Cancer Research 1521
08 Jun 2006 Independent Data Monitoring Board Recommends that Satraplatin Phase 3 Trial Continue as Planned 1278
08 Jun 2006 Evotec Announces Positive Phase I/II Clinical Trial Results with Insomnia Treatment EVT 201 1289
07 Jun 2006 GlaxoSmithKline and Galapagos enter into drug discovery and development alliance in Osteoarthritis 1333
06 Jun 2006 Results of PERSIST study with oral levosimendan 1225
06 Jun 2006 SR Pharma plc Announces a Key Technical Breakthrough With its Lyophilized (Dry Powder) Liposomal-Based siRNA Formulation 1258
06 Jun 2006 Novartis strengthens infectious disease portfolio by acquiring rights to Albuferon(TM), a hepatitis C interferon drug set to enter Phase III trials 1621
05 Jun 2006 FDA Approves the Reintroduction of TYSABRI® for the Treatment of Relapsing Forms of Multiple Sclerosis 1326
01 Jun 2006 The Debiopharm Group To Initiate Confirmatory Phase III Trial For Sanvar In Esophageal Variceal Bleeding 1268
01 Jun 2006 Update On Regulatory Filing Plans For Yondelis In Soft Tissue Sarcomas 1424
31 May 2006 Positive results for Intercell's Japanese Encephalitis virus vaccine in pivotal clinical trial 1228
31 May 2006 Pharmexa will start phase II trial in liver cancer with GV1001 1307
31 May 2006 Sandoz gets precedent-setting US approval for Omnitrope as first followon version of a previously approved recombinant biotechnology drug 1173
31 May 2006 MediGene AG Presents Positive Safety Data from the Clinical Phase I/II Trial of Cancer-Killing Virus NV1020 1208
31 May 2006 Crucell Announces Large Human Clinical Trial with Avian Influenza Vaccine 1145
30 May 2006 Granted national marketing authorisation 1238
29 May 2006 Actavis launches three new generic products in Europe 1330
24 May 2006 New Research Signals Second Indication for Interferon Beta Programme in COPD 1194
23 May 2006 Genmab Initiates Humax-CD20 CLL Pivotal Study 1175
23 May 2006 Oxford Biomedica Commences Phase II Trial Of Trovax In Prostate Cancer 1195
22 May 2006 Crucell Announces PER.C6® and ceNOS Licensing Agreements with BIOA&D 1311
22 May 2006 Debiopharm And TcLand Sign R&D And Exclusive License Option For The Development Of Sc28AT In Autoimmune Diseases And Transplantation 1363
17 May 2006 Phase III Community-Acquired Pneumonia Study Opens for Basilea’s Novel Broad-spectrum anti-MRSA Antibiotic Ceftobiprole to Broaden Indications 1257
17 May 2006 Basilea Completes Patient Recruitment of Alitretinoin Pivotal Phase III Study in Patients with Severe Chronic Hand Dermatitis 1249
16 May 2006 NicOx and Ferrer Select Candidate for Development In Dermatology Collaboration 1255
 
<< Start < Prev 1 2 3 4 5 6 7 8 Next > End >>
Results 1 - 30 of 228

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Biologic and Immune Therapy of S. aureus Infections

Order Now

Recommended Report

Oncology Market Leaders
Order Now

Subscribe La Merie Biologics